News-Medical.Net on MSN

Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children

Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may ...

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may ...
STAT

FDA approves first new kind of drug to target gonorrhea in decades

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...
Study Finds

Study: Lack of Diversity in Drug Trials Can Harm Patients

Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...
News - University of California, Riverside

FDA drug trials exclude a widening slice of Americans

A UCR study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country’s racial and ethnic ...

Scientists stunned: New vaccine shows hope against deadliest breast cancer

An experimental vaccine targeting aggressive triple-negative breast cancer (TNBC) has shown encouraging early results in clinical trials. The vaccine ...
News-Medical.Net

Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...
The Malaysian Reserve

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Vaccine Was Safe and Well Tolerated at the Maximum Tolerated DoseResults Support Advancement of the Program into Phase 2 DevelopmentCombination of ...
The Malaysian Reserve

New Lancet Phase III Study Shows Proton Therapy Significantly Improves Survival and Reduces Toxicity in Head and Neck Cancers – Marking a Breakthrough in Advanced Cancer Care

Ten percent higher 5-year overall survival rates in patients receiving precise proton therapy vs. traditional radiation therapyPatients had significantly ...

Phase I trial finds breast cancer vaccine triggers an immune response and is safe

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple ...